Semin Thromb Hemost
DOI: 10.1055/s-0043-1769079
Review Article

Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease

Jin K. Park
1   Division of Health, Sciences, and Technology, Massachusetts Institute of Technology and Harvard Medical School, Boston, Massachusetts
Marisa A. Brake
2   Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
Sol Schulman
1   Division of Health, Sciences, and Technology, Massachusetts Institute of Technology and Harvard Medical School, Boston, Massachusetts
2   Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
3   Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
› Author Affiliations


Tissue factor (TF) is the primary initiator of blood coagulation in humans. As improper intravascular TF expression and procoagulant activity underlie numerous thrombotic disorders, there has been longstanding interest in the contribution of heritable genetic variation in F3, the gene encoding TF, to human disease. This review seeks to comprehensively and critically synthesize small case–control studies focused on candidate single nucleotide polymorphisms (SNPs), as well as modern genome-wide association studies (GWAS) seeking to discover novel associations between variants and clinical phenotypes. Where possible, correlative laboratory studies, expression quantitative trait loci, and protein quantitative trait loci are evaluated to glean potential mechanistic insights. Most disease associations implicated in historical case–control studies have proven difficult to replicate in large GWAS. Nevertheless, SNPs linked to F3, such as rs2022030, are associated with increased F3 mRNA expression, monocyte TF expression after endotoxin exposure, and circulating levels of the prothrombotic biomarker D-dimer, consistent with the central role of TF in the initiation of blood coagulation.

Publication History

Article published online:
18 May 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

  • References

  • 1 Morrissey JH, Fakhrai H, Edgington TS. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987; 50 (01) 129-135
  • 2 Fisher KL, Gorman CM, Vehar GA, O'Brien DP, Lawn RM. Cloning and expression of human tissue factor cDNA. Thromb Res 1987; 48 (01) 89-99
  • 3 Scarpati EM, Wen D, Broze Jr GJ. et al. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 1987; 26 (17) 5234-5238
  • 4 Spicer EK, Horton R, Bloem L. et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A 1987; 84 (15) 5148-5152
  • 5 Banner DW, D'Arcy A, Chène C. et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380 (6569): 41-46
  • 6 Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A 1977; 74 (12) 5260-5264
  • 7 Lawson JH, Butenas S, Mann KG. The evaluation of complex-dependent alterations in human factor VIIa. J Biol Chem 1992; 267 (07) 4834-4843
  • 8 Neuenschwander PF, Branam DE, Morrissey JH. Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity. Thromb Haemost 1993; 70 (06) 970-977
  • 9 Ruf W, Rehemtulla A, Morrissey JH, Edgington TS. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991; 266 (04) 2158-2166
  • 10 Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988; 53 (04) 505-518
  • 11 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134 (05) 1087-1097
  • 12 Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9 (10) 883-889
  • 13 Grzegorski SJ, Zhao Y, Richter CE. et al. Genetic duplication of tissue factor reveals subfunctionalization in venous and arterial hemostasis. PLoS Genet 2022; 18 (11) e1010534
  • 14 Westrick RJ, Tomberg K, Siebert AE. et al. Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci. Proc Natl Acad Sci U S A 2017; 114 (36) 9659-9664
  • 15 Erlich J, Parry GCN, Fearns C. et al. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U S A 1999; 96 (14) 8138-8143
  • 16 Pawlinski R, Fernandes A, Kehrle B. et al. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A 2002; 99 (24) 15333-15338
  • 17 Schulman S, El-Darzi E, Florido MHC. et al; NIHR BioResource. A coagulation defect arising from heterozygous premature termination of tissue factor. J Clin Invest 2020; 130 (10) 5302-5312
  • 18 Ruf W, Dorfleutner A, Riewald M. Specificity of coagulation factor signaling. J Thromb Haemost 2003; 1 (07) 1495-1503
  • 19 Versteeg HH, Ruf W. Emerging insights in tissue factor-dependent signaling events. Semin Thromb Hemost 2006; 32 (01) 24-32
  • 20 Rak J, Milsom C, Yu J. Tissue factor in cancer. Curr Opin Hematol 2008; 15 (05) 522-528
  • 21 Belting M, Dorrell MI, Sandgren S. et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 2004; 10 (05) 502-509
  • 22 Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze Jr GJ. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88 (05) 1583-1587
  • 23 Bugge TH, Xiao Q, Kombrinck KW. et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci U S A 1996; 93 (13) 6258-6263
  • 24 Carmeliet P, Mackman N, Moons L. et al. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383 (6595): 73-75
  • 25 Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9 (04) 458-462
  • 26 Mackman N. Alternatively spliced tissue factor - one cut too many?. Thromb Haemost 2007; 97 (01) 5-8
  • 27 Oeth P, Parry GC, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 1997; 17 (02) 365-374
  • 28 Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol 1995; 15 (05) 612-621
  • 29 Mackman N, Fowler BJ, Edgington TS, Morrissey JH. Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci U S A 1990; 87 (06) 2254-2258
  • 30 Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of thrombosis. Arterioscler Thromb Vasc Biol 2018; 38 (04) 709-725
  • 31 Gajsiewicz JM, Morrissey JH. Structure-function relationship of the interaction between tissue factor and factor VIIa. Semin Thromb Hemost 2015; 41 (07) 682-690
  • 32 Arnaud E, Barbalat V, Nicaud V. et al. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis Case-Control Study. Arterioscler Thromb Vasc Biol 2000; 20 (03) 892-898
  • 33 Mälarstig A, Tenno T, Johnston N. et al. Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 2005; 25 (12) 2667-2672
  • 34 Inzitari D. Leukoaraiosis: an independent risk factor for stroke?. Stroke 2003; 34 (08) 2067-2071
  • 35 Smith JA, Turner ST, Sun YV. et al. Complexity in the genetic architecture of leukoaraiosis in hypertensive sibships from the GENOA Study. BMC Med Genomics 2009; 2: 16
  • 36 Undas A, Stepien E, Potaczek DP, Tracz W. Tissue factor +5466A>G polymorphism determines thrombin formation following vascular injury and thrombin-lowering effects of simvastatin in patients with ischemic heart disease. Atherosclerosis 2009; 204 (02) 567-572
  • 37 Dahm AEA, Bezemer ID, Bergrem A. et al. Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis. Br J Haematol 2012; 157 (06) 753-761
  • 38 Hisada Y, Mackman N. Tissue factor and cancer: regulation, tumor growth, and metastasis. Semin Thromb Hemost 2019; 45 (04) 385-395
  • 39 Potaczek DP, Kwasny-Krochin B, Nishiyama C, Okumura K, Gluszko P, Undas A. Tissue factor +5466A>G and -1208D>I genetic polymorphisms and severity of rheumatoid arthritis. Clin Chem Lab Med 2010; 48 (03) 423-425
  • 40 Shi D, Song Z, Yin J. et al. Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis patients. Crit Care 2014; 18 (06) 631
  • 41 Tinholt M, Viken MK, Dahm AE. et al. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study. BMC Cancer 2014; 14: 845
  • 42 Tinholt M, Vollan HKM, Sahlberg KK. et al. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF. Breast Cancer Res 2015; 17 (01) 44
  • 43 Poursafa P, Kelishadi R, Moattar F. et al. Genetic variation in the association of air pollutants with a biomarker of vascular injury in children and adolescents in Isfahan, Iran. J Res Med Sci 2011; 16 (06) 733-740
  • 44 Poursafa P, Kelishadi R, Haghjooy-Javanmard S, Rafiei L, Keramatian K. Synergistic effects of genetic polymorphism and air pollution on markers of endothelial dysfunction in children. J Res Med Sci 2012; 17 (08) 718-723
  • 45 Reny J-L, Laurendeau I, Fontana P. et al. The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers. Thromb Haemost 2004; 91 (02) 248-254
  • 46 Potaczek DP, Pieculewicz M, Mazur M. et al. Tissue factor +5466A>G polymorphism predicts plasma TF levels in subjects with cryptogenic ischaemic stroke. Thromb Haemost 2009; 102 (01) 173-175
  • 47 Isada A, Konno S, Hizawa N. et al. A functional polymorphism (-603A –> G) in the tissue factor gene promoter is associated with adult-onset asthma. J Hum Genet 2010; 55 (03) 167-174
  • 48 Ott I, Koch W, von Beckerath N. et al. Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction. Atherosclerosis 2004; 177 (01) 189-191
  • 49 Liang Y, Kelemen A. Shared polymorphisms and modifiable behavior factors for myocardial infarction and high cholesterol in a retrospective population study. Medicine (Baltimore) 2017; 96 (37) e7683
  • 50 Opstad TB, Pettersen AÅ, Weiss T, Arnesen H, Seljeflot I. Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes. Thromb J 2010; 8: 7
  • 51 Sakowicz A, Fendler W, Lelonek M, Sakowicz B, Pietrucha T. Genetic polymorphisms and the risk of myocardial infarction in patients under 45 years of age. Biochem Genet 2013; 51 (3-4): 230-242
  • 52 Shaffer JR, Kammerer CM, Dorn J. et al. Polymorphisms in the platelet-specific collagen receptor GP6 are associated with risk of nonfatal myocardial infarction in Caucasians. Nutr Metab Cardiovasc Dis 2011; 21 (08) 546-552
  • 53 De Gaetano M, Quacquaruccio G, Pezzini A. et al. Tissue factor gene polymorphisms and haplotypes and the risk of ischemic vascular events: four studies and a meta-analysis. J Thromb Haemost 2009; 7 (09) 1465-1471
  • 54 Castillo MM, Yang Q, Zhan M. et al. Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency. Blood Adv 2019; 3 (03) 489-498
  • 55 Biguzzi E, Franchi F, Acaia B. et al. Genetic background and risk of postpartum haemorrhage: results from an Italian cohort of 3219 women. Haemophilia 2014; 20 (06) e377-e383
  • 56 Moffatt MF, Gut IG, Demenais F. et al; GABRIEL Consortium. A large-scale, consortium-based genome wide association study of asthma. N Engl J Med 2010; 363 (13) 1211-1221
  • 57 Marsik C, Endler G, Halama T. et al. Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytes. J Thromb Haemost 2006; 4 (04) 745-749
  • 58 Potaczek DP, Owczarek D, Cibor D. et al. Tissue factor -1208D>I polymorphism is associated with D-dimer levels in patients with inflammatory bowel disease. Inflamm Bowel Dis 2010; 16 (07) 1095-1096
  • 59 Raffield LM, Zakai NA, Duan Q. et al; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Hematology & Hemostasis TOPMed Working Group*. D-dimer in African Americans. Arterioscler Thromb Vasc Biol 2017; 37 (11) 2220-2227
  • 60 Sherman BT, Hu X, Singh K. et al; ESPRIT, SMART and START Study Groups. Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohorts. AIDS 2021; 35 (02) 193-204
  • 61 Karczewski KJ, Francioli LC, Tiao G. et al; Genome Aggregation Database Consortium. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020; 581 (7809): 434-443
  • 62 Gimenez LG, Momany AM, Poletta FA. et al. Association of candidate gene polymorphisms with clinical subtypes of preterm birth in a Latin American population. Pediatr Res 2017; 82 (03) 554-559
  • 63 Romero R, Velez Edwards DR, Kusanovic JP. et al. Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes. Am J Obstet Gynecol 2010; 202 (05) 431.e1-431.e34
  • 64 Romero R, Friel LA, Velez Edwards DR. et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol 2010; 203 (04) 361.e1-361.e30
  • 65 Thuong NT, Hawn TR, Chau TT. et al. Epiregulin (EREG) variation is associated with susceptibility to tuberculosis. Genes Immun 2012; 13 (03) 275-281
  • 66 Tam V, Patel N, Turcotte M, Bossé Y, Paré G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet 2019; 20 (08) 467-484
  • 67 Wain LV, Shrine N, Miller S. et al; UK Brain Expression Consortium (UKBEC), OxGSK Consortium. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir Med 2015; 3 (10) 769-781
  • 68 Uffelmann E, Huang QQ, Munung NS. et al. Genome-wide association studies. Nat Rev Methods Primers 2021; 1: 1-21
  • 69 Smith NL, Huffman JE, Strachan DP. et al. Genetic predictors of fibrin D-dimer levels in healthy adults. Circulation 2011; 123 (17) 1864-1872
  • 70 Williams FMK, Carter AM, Hysi PG. et al; EuroCLOT Investigators, Wellcome Trust Case Control Consortium 2, MOnica Risk, Genetics, Archiving and Monograph, MetaStroke, International Stroke Genetics Consortium. Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol 2013; 73 (01) 16-31
  • 71 Peterson RE, Kuchenbaecker K, Walters RK. et al. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell 2019; 179 (03) 589-603
  • 72 Karny-Epstein N, Abuhasira R, Grossman A. Current use of D-dimer for the exclusion of venous thrombosis in hospitalized patients. Sci Rep 2022; 12 (01) 12376
  • 73 Smith NL, Heit JA, Tang W, Teichert M, Chasman DI, Morange PE. Venous Thrombosis Genetic Replication Consortium. Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies. J Thromb Haemost 2012; 10 (04) 719-722
  • 74 Ghouse J, Tragante V, Ahlberg G. et al. Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism. Nat Genet 2023; 55 (03) 399-409
  • 75 Dehghan A, Bis JC, White CC. et al. Genome-wide association study for incident myocardial infarction and coronary heart disease in prospective cohort studies: the CHARGE Consortium. PLoS One 2016; 11 (03) e0144997
  • 76 Keene KL, Hyacinth HI, Bis JC. et al; COMPASS, SiGN, and METASTROKE Consortia. Genome-wide association study meta-analysis of stroke in 22 000 individuals of African descent identifies novel associations with stroke. Stroke 2020; 51 (08) 2454-2463
  • 77 Hartiala JA, Han Y, Jia Q. et al; INVENT Consortium, CHARGE Consortium Hemostasis Working Group, GENIUS-CHD Consortium, Biobank Japan. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur Heart J 2021; 42 (09) 919-933
  • 78 Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 (10223): 507-513
  • 79 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229): 1054-1062
  • 80 Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18 (04) 844-847
  • 81 Ramlall V, Thangaraj PM, Meydan C. et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med 2020; 26 (10) 1609-1615
  • 82 Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA 2020; 324 (08) 799-801
  • 83 Shelton JF, Shastri AJ, Ye C. et al; 23andMe COVID-19 Team. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat Genet 2021; 53 (06) 801-808
  • 84 Karlsen TH. Understanding COVID-19 through genome-wide association studies. Nat Genet 2022; 54 (04) 368-369
  • 85 Niemi MEK, Karjalainen J, Liao RG. et al; COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature 2021; 600 (7889): 472-477
  • 86 Lencz T, Knowles E, Davies G. et al. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Mol Psychiatry 2014; 19 (02) 168-174
  • 87 Yoshimura K, Morita Y, Konomi K. et al. A web-based survey on various symptoms of computer vision syndrome and the genetic understanding based on a multi-trait genome-wide association study. Sci Rep 2021; 11 (01) 9446
  • 88 Deng X, Sabino EC, Cunha-Neto E. et al; REDSII Chagas Study Group from the NHLBI Retrovirus Epidemiology Donor Study-II Component International. Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects. PLoS One 2013; 8 (11) e79629
  • 89 Cho Y, Cao X, Shen D. et al. Evidence for enhanced tissue factor expression in age-related macular degeneration. Lab Invest 2011; 91 (04) 519-526
  • 90 Folkersen L, Gustafsson S, Wang Q. et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab 2020; 2 (10) 1135-1148
  • 91 GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 2020; 369 (6509): 1318-1330
  • 92 Foster MW. International HapMap Consortium. Integrating ethics and science in the International HapMap Project. Nat Rev Genet 2004; 5 (06) 467-475
  • 93 Little J, Bradley L, Bray MS. et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002; 156 (04) 300-310
  • 94 Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost 2010; 36 (08) 865-875
  • 95 Kimchi-Sarfaty C, Oh JM, Kim I-W. et al. A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315 (5811): 525-528
  • 96 Nackley AG, Shabalina SA, Tchivileva IE. et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006; 314 (5807): 1930-1933
  • 97 Shatoff E, Bundschuh R. Single nucleotide polymorphisms affect RNA-protein interactions at a distance through modulation of RNA secondary structures. PLOS Comput Biol 2020; 16 (05) e1007852
  • 98 Potaczek DP, Pieculewicz M, Mazur M. et al. Very rare minor homozygous GG genotype of tissue factor +5466A>G mutation in a patient with two cryptogenic cerebrovascular ischemic events. Int J Cardiol 2011; 147 (01) e13-e15
  • 99 Palmer ND, McDonough CW, Hicks PJ. et al; DIAGRAM Consortium, MAGIC Investigators. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One 2012; 7 (01) e29202
  • 100 Sollis E, Mosaku A, Abid A. et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res 2023; 51 ( D1) D977-D985